[1] DREYMUELLER D, PRUESSMEYER J, GROTH E, et al. The role of ADAM-mediated shedding in vascular biology[J]. Eur J Cell Biol, 2012, 91(6-7):472-485.
[2] KWON J, JEONG S M, CHOI I, et al. ADAM10 is involved in cell junction assembly in early porcine embryo development[J]. PLoS One, 2016, 11(4):e0152921.
[3] CHANTRY A, GREGSON N A, GLYNN P. A novel metalloproteinase associated with brain myelin membranes. Isolation and characterization[J]. J Biol Chem, 1989, 264(36):21603-21607.
[4] FOLKESSON M, LI C, FREBELIUS S, et al. Proteolytically active ADAM10 and ADAM17 carried on membrane microvesicles in human abdominal aortic aneurysms[J]. Thromb Haemost, 2015, 114(6):1165-1174.
[5] SEALS D F, COURTNEIDGE S A. The ADAMs family of metalloproteases:multidomain proteins with multiple functions[J]. Genes Dev, 2003, 17(1):7-30.
[6] ZHUANG J L, WEI Q L, LIN Z H, et al. Effects of ADAM10 deletion on Notch-1 signaling pathway and neuronal maintenance in adult mouse brain[J]. Gene, 2015, 555(2):150-158.
[7] FENG L Z, WANG Y J, CAI H, et al. ADAM10-Notch signaling governs the recruitment of ovarian pregranulosa cells and controls folliculogenesis in mice[J]. J Cell Sci, 2016, 129(11):2202-2212.
[8] MURAI T, MIYAUCHI T, YANAGIDA T, et al. Epidermal growth factor-regulated activation of Rac GTPase enhances CD44 cleavage by metalloproteinase disintegrin ADAM10[J]. Biochem J, 2006, 395(1):65-71.
[9] PAN Y, HAN C, WANG C L, et al. ADAM10 promotes pituitary adenoma cell migration by regulating cleavage of CD44 and L1[J]. J Mol Endocrinol, 2012, 49(1):21-33.
[10] ANDEREGG U, EICHENBERG T, PARTHAUNE T, et al. ADAM10 is the constitutive functional sheddase of CD44 in human melanoma cells[J]. J Invest Dermatol, 2009, 129(6):1471-1482.
[11] YANG K, LU L, LIU Y, et al. Increase of ADAM10 level in coronary artery in-stent restenosis segments in diabetic minipigs:high ADAM10 expression promoting growth and migration in human vascular smooth muscle cells via Notch 1 and 3[J]. PLoS One, 2013, 8(12):e83853.
[12] KANDA K, KOMEKADO H, SAWABU T, et al. Nardilysin and ADAM proteases promote gastric cancer cell growth by activating intrinsic cytokine signalling via enhanced ectodomain shedding of TNF-α[J]. EMBO Mol Med, 2012, 4(5):396-411.
[13] LOREY M B, ROSSI K, EKLUND K K, et al. Global characterization of protein secretion from human macrophages following non-canonical caspase-4/5 inflammasome activation[J]. Mol Cell Proteomics, 2017, 16(4 Suppl 1):S187-S199, doi:10.1074/mcp.M116.064840.
[14] BLACK D L. Mechanisms of alternative pre-messenger RNA splicing[J]. Annu Rev Biochem, 2003, 72:291-336.
[15] 万敬员, 张力, 叶笃筠. 选择性剪接调控机制的研究进展[J]. 国外医学分子生物学分册, 2003, 25(6):342-345.
WAN J Y, ZHANG L, YE D Y. Research advances on mechanisms of alternative splicing regulation[J]. Journal of Medical Molecular Biology, 2003, 25(6):342-345.(in Chinese)
[16] VUONG C K, BLACK D L, ZHENG S K. The neurogenetics of alternative splicing[J]. Nat Rev Neurosci, 2016, 17(5):265-281.
[17] ARDUISE C, ABACHE T, LI L, et al. Tetraspanins regulate ADAM10-mediated cleavage of TNF-α and epidermal growth factor[J]. J Immunol, 2008, 181(10):7002-7013.
[18] VINCENT B. Regulation of the α-secretase ADAM10 at transcriptional, translational and post-translational levels[J]. Brain Res Bull, 2016, 126(Pt 2):154-169.
[19] ANDERS A, GILBERT S, GARTEN W, et al. Regulation of the α-secretase ADAM10 by its prodomain and proprotein convertases[J]. FASEB J, 2001, 15(10):1837-1839.
[20] MOCHIZUKI S, OKADA Y. ADAMs in cancer cell proliferation and progression[J]. Cancer Sci, 2007, 98(5):621-628.
[21] 潘源, 丁学华. 抗癌治疗新靶标——去整合素金属蛋白酶10[J]. 国际肿瘤学杂志, 2011, 38(7):492-495.
PAN Y, DING X H. A new anti-cancer target:ADAM10[J]. Journal of International Oncology, 2011, 38(7):492-495. (in Chinese)
[22] LUNN C A, FAN X D, DALIE B, et al. Purification of ADAM 10 from bovine spleen as a TNFα convertase[J].FEBS Lett, 1997, 400(3):333-335. |